NovoCure Limited logo
NovoCure Limited NVCR
$ 17.96 0.34%

Annual report 2025
added 02-26-2026

report update icon

NovoCure Limited EV/EBITDA Ratio 2011-2026 | NVCR

Annual EV/EBITDA Ratio NovoCure Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-243 417 1.1 K -176 -64.3 -4.73 -2.81 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.1 K -243 146

EV/EBITDA Ratio of other stocks in the Health care industry

Issuer EV/EBITDA Ratio Price % 24h Market Cap Country
Anthem Anthem
ANTM
19.2 - -2.32 % $ 107 B usaUSA
CVS Health Corporation CVS Health Corporation
CVS
28.7 $ 93.26 -0.06 % $ 118 B usaUSA
Triple-S Management Corporation Triple-S Management Corporation
GTS
79.5 - 0.28 % $ 847 M usaUSA
Magellan Health, Inc. Magellan Health, Inc.
MGLN
16.1 - -0.19 % $ 2.49 B usaUSA
UnitedHealth Group Inc. UnitedHealth Group Inc.
UNH
21.6 $ 388.47 1.57 % $ 353 B usaUSA
Centene Corporation Centene Corporation
CNC
26.4 $ 59.14 2.37 % $ 29.2 B usaUSA
Molina Healthcare Molina Healthcare
MOH
20.4 $ 184.14 1.59 % $ 9.72 B usaUSA
Cigna Corporation Cigna Corporation
CI
9.45 $ 286.24 1.5 % $ 75.4 B usaUSA
Humana Humana
HUM
21.3 $ 307.95 1.41 % $ 37.1 B usaUSA